CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 84 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$459,710
-13.8%
145,478
+5.6%
0.00%
Q2 2023$533,348
+46.3%
137,816
+4.7%
0.00%
Q1 2023$364,540
+59.5%
131,603
+3.6%
0.00%
Q4 2022$228,611
-15.3%
127,0060.0%0.00%
Q3 2022$270,000
-21.1%
127,0060.0%0.00%
Q2 2022$342,000
+252.6%
127,006
+470.7%
0.00%
Q1 2022$97,000
-16.4%
22,2560.0%0.00%
Q4 2021$116,000
-15.3%
22,2560.0%0.00%
Q3 2021$137,00022,2560.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders